Skip to content

Expiring federal contract · order under a contract vehicle

75N91025F00001 — The Univeristy Of Texas M.d. Anderson Cancer Center

Department of Health and Human Services · National Institutes of Health

Contract / PIID
75N91025F00001
Incumbent
The Univeristy Of Texas M.d. Anderson Cancer Center
Incumbent UEI
S3GMKS8ELA16
Current end date
March 24, 2028
Potential total value
$1,324,125
Obligated
$1,324,125
NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Set-aside
SB-Total
Start date
September 25, 2025
Place of performance
TX
Award type
DELIVERY ORDER

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC)

Likely rebid window (estimate)

  • Sources Sought / RFI: about Mar 2027 – Sep 2027 (6–12 months before the end date)
  • RFP: about Nov 2027 – Jan 2028 (2–4 months before the end date)

Early: the estimated Sources Sought window has not opened yet.

This is an order under contract vehicle 75N91024D00004. Orders are usually not competed on their own: the next order may be placed under the same vehicle.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: 2 recorded changes to the end date, value or incumbent. Sign up to see each one.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Health and Human Services (NAICS 541714)